When Harry Travis first met Neil Euliano and learned about his medication adherence technology, the pharmaceutical industry was beginning to usher in the age of pricey drugs with Hepatitis C therapies that hit the market at prices like $500 or $1,000 dollars a pill.
“It just so happened at the time, really expensive medications were front and center in everybody’s mind in the world of pharmacy,” Travis told Drug Delivery Business News. “No one had ever experienced a $1,000 pill. That was a first through the industry. We were all in sticker shock.”
Travis would know – he’s a pharmacist and has worked in an array of well-known companies in the healthcare industry, including Baxter and Cardinal Health.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.